Video
Dr. Scarpato highlights case-based discussion on intermediate-risk NMIBC
Author(s):
“[I focused on] why this such an important topic and how we might better counsel our patients,” says Kristen Scarpato, MD, MPH.
Video Player is loading.
In this video, Kristen Scarpato, MD, MPH, discusses key points of a case-based discussion on intermediate-risk non-muscle invasive bladder cancer taking place during the 2021 Society of Urologic Oncology Annual Meeting. Scarpato is an associate professor, residency program director, and vice chair of education in the department of urology at the Vanderbilt University Medical Center in Nashville, Tennessee.
Related Videos
Roger Dmochowski, MD, on real-world persistence with vibegron for OAB
Sam Chang, MD, shares updated data on nogapendekin alfa inbakicept in NMIBC
5 key trial insights from AUA 2025
Shreyas Joshi, MD, recaps AUA session on chemotherapy vs novel NMIBC options
Shay Rajavel, MS3, on CO2 gas embolism during single-port partial nephrectomy
Kevin Zorn, MD, on preserving ejaculation with BPH therapies
Neal Shore, MD, on sasanlimab plus BCG for BCG-naïve NMIBC
Alexander Glaser, MD, on real-world outcomes with Aquablation
Vitaly Margulis, MD, on preliminary safety, efficacy of padeliporfin VTP for UTUC
Joseph Jacob, MD, on the durability of TAR-200 in NMIBC
Related Content
